Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 3
1977 3
1978 7
1979 13
1980 8
1981 12
1982 16
1983 22
1984 27
1985 39
1986 37
1987 66
1988 42
1989 47
1990 61
1991 58
1992 78
1993 47
1994 49
1995 48
1996 49
1997 56
1998 47
1999 40
2000 41
2001 35
2002 49
2003 55
2004 54
2005 51
2006 54
2007 58
2008 61
2009 52
2010 76
2011 81
2012 82
2013 105
2014 88
2015 80
2016 64
2017 81
2018 79
2019 78
2020 108
2021 85
2022 69
2023 50
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

2,341 results

Results by year

Filters applied: . Clear all
Page 1
Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota.
Ma SR, Tong Q, Lin Y, Pan LB, Fu J, Peng R, Zhang XF, Zhao ZX, Li Y, Yu JB, Cong L, Han P, Zhang ZW, Yu H, Wang Y, Jiang JD. Ma SR, et al. Signal Transduct Target Ther. 2022 Jul 7;7(1):207. doi: 10.1038/s41392-022-01027-6. Signal Transduct Target Ther. 2022. PMID: 35794102 Free PMC article.

Moreover, 21 patients with atherosclerosis exhibited the average decrease of plaque score by 3.2% after oral BBR (0.5 g, bid) for 4 months (*P < 0.05, n = 21); whereas the plaque score in patients treated with rosuvastatin plus aspirin, or clopidogrel sulfate or ticagre

…
Moreover, 21 patients with atherosclerosis exhibited the average decrease of plaque score by 3.2% after oral BBR (0.5 g, bid) for 4 m …
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.
Wollenhaupt J, Lee EB, Curtis JR, Silverfield J, Terry K, Soma K, Mojcik C, DeMasi R, Strengholt S, Kwok K, Lazariciu I, Wang L, Cohen S. Wollenhaupt J, et al. Arthritis Res Ther. 2019 Apr 5;21(1):89. doi: 10.1186/s13075-019-1866-2. Arthritis Res Ther. 2019. PMID: 30953540 Free PMC article. Clinical Trial.
Assignment to dose groups (5 mg or 10 mg BID) was based on patients' average total daily dose. The primary objective was to determine the long-term safety and tolerability of tofacitinib 5 mg and 10 mg BID; the key secondary objective was to evaluate the long-term p …
Assignment to dose groups (5 mg or 10 mg BID) was based on patients' average total daily dose. The primary objective was to determine …
Exercise-induced signaling pathways to counteracting cardiac apoptotic processes.
Pahlavani HA. Pahlavani HA. Front Cell Dev Biol. 2022 Aug 11;10:950927. doi: 10.3389/fcell.2022.950927. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36036015 Free PMC article. Review.
Cardiovascular diseases are the most common cause of death in the world. ...In addition, after exercise mitochondrial-dependent apoptotic factors such as Bid, t-Bid, Bad, p-Bad, Bak, cytochrome c, and caspase-9 are reduced. ...
Cardiovascular diseases are the most common cause of death in the world. ...In addition, after exercise mitochondrial-dependen …
Prevalence and pattern of cardiovascular-related causes of out-of- hospital deaths in Lagos, Nigeria.
Adegoke O, Awolola NA, Ajuluchukwu JN. Adegoke O, et al. Afr Health Sci. 2018 Dec;18(4):942-949. doi: 10.4314/ahs.v18i4.13. Afr Health Sci. 2018. PMID: 30766558 Free PMC article.
BACKGROUND: In developed countries 50% - 75% of deaths from cardiovascular-diseases occurs out-of-hospital. In Nigeria where patronage of orthodox health facilities is low, the impact of cardiovascular-related diseases on out-of-hospital mortality has …
BACKGROUND: In developed countries 50% - 75% of deaths from cardiovascular-diseases occurs out-of-hospital. In Nigeria where p …
Endoplasmic Reticulum Stress: A Key Regulator of Cardiovascular Disease.
Chen Z, Zhang SL. Chen Z, et al. DNA Cell Biol. 2023 Jun;42(6):322-335. doi: 10.1089/dna.2022.0532. Epub 2023 May 3. DNA Cell Biol. 2023. PMID: 37140435 Review.
The problems associated with economic development and social progress have led to an increase in the occurrence of cardiovascular diseases (CVDs), which affect the health of an increasing number of people and are a leading cause of disease and population mortality w …
The problems associated with economic development and social progress have led to an increase in the occurrence of cardiovascular …
Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.
Douxfils J, Buckinx F, Mullier F, Minet V, Rabenda V, Reginster JY, Hainaut P, Bruyère O, Dogné JM. Douxfils J, et al. J Am Heart Assoc. 2014 Jun 6;3(3):e000515. doi: 10.1161/JAHA.113.000515. J Am Heart Assoc. 2014. PMID: 24906369 Free PMC article. Review.
Criteria for inclusion in our meta-analysis included all RCTs and the availability of outcome data for MI, other cardiovascular events, major bleeding, and all-cause mortality. Among the 501 unique references identified, 14 RCTs fulfilled the inclusion criteria. ...The res …
Criteria for inclusion in our meta-analysis included all RCTs and the availability of outcome data for MI, other cardiovascular event …
Adherence and dosing frequency of common medications for cardiovascular patients.
Bae JP, Dobesh PP, Klepser DG, Anderson JD, Zagar AJ, McCollam PL, Tomlin ME. Bae JP, et al. Am J Manag Care. 2012 Mar;18(3):139-46. Am J Manag Care. 2012. PMID: 22435907 Free article.
OBJECTIVES: To compare adherence between once-daily (QD) and twice-daily (BID) dosing with chronic-use prescription medications used by patients with cardiovascular disease. ...For cardiac agents, the adjusted mean MPR value was similar between QD and BID age …
OBJECTIVES: To compare adherence between once-daily (QD) and twice-daily (BID) dosing with chronic-use prescription medications used …
Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study.
Salisbury-Ruf CT, Bertram CC, Vergeade A, Lark DS, Shi Q, Heberling ML, Fortune NL, Okoye GD, Jerome WG, Wells QS, Fessel J, Moslehi J, Chen H, Roberts LJ 2nd, Boutaud O, Gamazon ER, Zinkel SS. Salisbury-Ruf CT, et al. Elife. 2018 Oct 3;7:e40907. doi: 10.7554/eLife.40907. Elife. 2018. PMID: 30281024 Free PMC article.
Bid-/- mice display stress-induced myocardial dysfunction and damage. ...Furthermore, Bid but not Bid(M148T) associates with Mcl-1(Matrix), previously implicated in cristae stability; decreased MCL-1 expression associates with MI. ...
Bid-/- mice display stress-induced myocardial dysfunction and damage. ...Furthermore, Bid but not Bid(M148T) associates …
Can We Slow Down Biological Age Progression? Study Protocol for the proBNPage Reduction (PBAR) Randomized, Double-Blind, Placebo-Controlled Trial (Effects of 4 "Anti-Aging" Food Supplements in Healthy Older Adults).
Muscari A, Forti P, Brizi M, Magalotti D, Capelli E, Potì S, Piro F, Pandolfi P, Perlangeli V, Ramazzotti E, Barbara G; PBAR Study Group. Muscari A, et al. Clin Interv Aging. 2023 Oct 27;18:1813-1825. doi: 10.2147/CIA.S422371. eCollection 2023. Clin Interv Aging. 2023. PMID: 37915546 Free PMC article.
PATIENTS AND METHODS: This is a double-blind randomized placebo-controlled clinical trial on 120 adults aged 65-80 years, free of cardiovascular diseases. Participants will be randomized into 3 groups: A) Coenzyme Q10 100 mg bid + Selenium 100 mcg; B) Resvera …
PATIENTS AND METHODS: This is a double-blind randomized placebo-controlled clinical trial on 120 adults aged 65-80 years, free of cardiov …
Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer.
Luo J, Song J, Xiao L, Zhang J, Cao Y, Wang J, Wang P, Zhao L, Liu N. Luo J, et al. Cancer Biol Med. 2023 Jun 9;20(6):452-64. doi: 10.20892/j.issn.2095-3941.2022.0326. Cancer Biol Med. 2023. PMID: 37300284 Free PMC article.
The radiation dose was 60 Gy for both PGTV and PTV QD in the C-QD cohort. The radiation dose was 45 Gy for both PGTV and PTV in the BID cohort. Toxicities, short-term effects, and survival outcomes were recorded. ...RESULTS: The median overall survival time (MST) in the 3 …
The radiation dose was 60 Gy for both PGTV and PTV QD in the C-QD cohort. The radiation dose was 45 Gy for both PGTV and PTV in the BID …
2,341 results